• English
  • Eesti
    NewsNews

    The Estonian medicinal products market in first quarter 2017

    15.05.2017
    Printer-friendly version

    Estonian drug statistics is based on wholesalers’ reports. The statistics of human medicinal products includes sales to general and hospital pharmacies and to other institutions, i.e. state and scientific institutions. The statistics of veterinary medicinal products includes sales to general and veterinary pharmacies, veterinarians and to other institutions. The medicinal products market is expressed in wholesale prices which includes the price of the manufacturer and wholesaler’s mark-up and does not include the VAT.

    Human medicines

    In the first quarter of 2017 the medicinal products market increased 3.4% reaching to 75.6 million euros. Estonian human medicines market of previous five years shows also an increasing trend:

    Sales to general pharmacies were 52.1 million euros, sales to hospital pharmacies 22.8 million euros and sales to other institutions 0.7 million euros.

    Prescription sales covered most of the medicinal products market, being 63.9 million euros. The turnovers of over the counter sales and hospital package sales were 11.1 million euros and 0.7 million euros.

    Based on ATC classification, the most sold medicines by turnover, were antineoplastic and immunomodulating agents (14.6  million euros), antiinfectives for systemic use  (12.1 million euros) and alimentary tract and metabolism medicines (8.7 million euros).

    Defined Daily Dose (DDD) is the assumed average dose per day for the drug used in its main indication in adults. Defined Daily Dose per thousand inhabitants a day (DDD/1000/day) expresses the proportion of the population within a defined area treated daily with certain drugs.

    According to DDD/1000/day the most consumed medicines in the first quarter of 2017 were cardiovascular system drugs (416 DDD/1000/day), alimentary tract and metabolism drugs (169 DDD/1000/day) and nervous system medicines (125 DDD/1000/day).

    The most consumed active substances were:

      

    ATC group / INN (rout of admin.)

    DDD/1000/day

    Ramipril

    58,74

    Acetylsalicylic acid +Magnesium oxide

    50,98

    Rosuvastatin

    28,99

    Ibuprofen

    27,64

    Amlodipine

    27,57

    Omeprazole

    25,36

    Xylometazoline

    24,20

    Metoprolol

    23,60

    Telmisartan

    20,85

    Nebivolol

    20,34

    In the first quarter of 2017, over 3600 different medicinal preparation packages and 1200 active substances were marketed in Estonia.

    Veterinary medicines

    The Estonian veterinary medicinal products market was 2.79 million euros in wholesale prices in the first quarter of 2017. Compared to the first quarter in 2016 the turnover increased 4.7%.

    Almost 90% of veterinary medicines were sold to the veterinarians or to the agricultural companies represented by a veterinarian, 6% to the veterinary pharmacies, 3% to the general pharmacies and 1% to other institutions (generally state- and scientific institutions).

    The most sold medicines by turnover were antiinfectives for systemic use (0.76 million euros), antiparasitic products (0.56 million euros) and immunologicals (0.55 million euros). Compared the data of first quarters of the last three years the turnover of antiinfectives decreased, the turnover of antiparasitic products and alimentary tract increased. The turnover of immunologicals decreased in 2016 and increased in 2017 compared to the previous year.